Search alternatives:
point decrease » point increase (Expand Search)
web decrease » we decrease (Expand Search), teer decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
point decrease » point increase (Expand Search)
web decrease » we decrease (Expand Search), teer decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
-
17141
Study characteristics.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17142
Age at treatment initiation–puberty suppression.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17143
Search terms.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17144
PRISMA diagram.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17145
PRISMA 2020 checklist.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17146
Recruitment of α5-GABA<sub>A</sub>Rs to PV-synapses contributes to wake-dependent enhancement of iLTP.
Published 2022“…(K) Representative PV-IPSC traces at indicated time points in (J). (L) L655,708 decreased the potentiation of PV-IPSC amplitude after NMDA application in wake and sleep-deprived mice (SD) but not sleep mice (<i>n</i> = 7–8, 2-way ANOVA, F (4, 38) = 4.234, <i>p</i> = 0.0062 with Sidak’s multiple comparison test, Sleep a versus Sleep b, <i>p</i> = 0.028; Sleep a versus Sleep c, <i>p</i> = 0.04; Wake a versus Wake b, <i>p</i> = 0.0014; Wake b versus Wake c, <i>p</i> = 0.023; Wake a versus Wake c, <i>p</i> = 0.0008; SD a versus SD b, <i>p</i> < 0.0001; SD b versus SD c, <i>p</i> = 0.0091; SD a versus SD c, <i>p</i> = 0.0002; Sleep b versus Wake b, <i>p</i> = 0.028; Sleep b versus SD b, <i>p</i> = 0.04). …”
-
17147
-
17148
-
17149
-
17150
Data_Sheet_1_Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.docx
Published 2021“…</p><p>Results: Among the 5 patients, 4 were males ranging from 35 to 80 year old (Mean age = 63 ± 17.87). …”
-
17151
-
17152
-
17153
Identification of Differentially Expressed Genes in the Pheromone Glands of Mated and Virgin <i>Bombyx mori</i> by Digital Gene Expression Profiling
Published 2014“…RNAi-mediated knockdown of putative JH receptor gene, <i>Methoprene tolerant 1</i> (<i>Met1</i>), in female pupa resulted in a significant decrease in sex pheromone production in mature females, suggesting the importance of JH in sex pheromone synthesis.…”
-
17154
Short-delay 5CSRTT testing.
Published 2024“…<p>A) There was a decrease in accuracy in offspring of poly I:C injected rats at the shortest delay of 0.5 s, regardless of genotype. …”
-
17155
-
17156
-
17157
Outline of study participants.
Published 2025“…</p><p>Results</p><p>This study was implemented on 2,688 men and 3,260 women, respectively with the mean (SD) age of 41.5(14.1) and 39.3(13.02) years. …”
-
17158
Genetic deletion of P2rx7 leads to the alteration of NA and 5-HT levels (A, B), elevation of<sup>3</sup>H-Citalopram binding sites and 5-HT uptake (C) in the mouse hippocampus.
Published 2013“…<p>A, B/NA and 5-HT levels were analyzed using HPLC in the hippocampus of naive and LPS (1 mg/kg)-treated P2rx7+/+ and P2rx7−/− mice. …”
-
17159
Table_5_The Advantage of Supine and Standing Heart Rate Variability Analysis to Assess Training Status and Performance in a Walking Ultramarathon.DOCX
Published 2020“…There were no significant differences in both supine and standing HRV between finishers (n = 14) and non-finishers (n = 11, mean distance 67 km). In finishers, a slower race velocity was significantly correlated with a higher decrease in parasympathetic drive during position change [larger decrease in High Frequency power normalized units (HF<sub>nu</sub>: r = −0.7, p = 0.01) and higher increase in the detrended fluctuation analysis alpha 1 index (DFA1: r = 0.6, p = 0.04)]. …”
-
17160